Vericiguat (Verquvo, BAY1021189)
Sponsors
Bayer
Conditions
Chronic Heart FailureChronic Heart Failure With Reduced Ejection FractionWorsening Chronic Heart FailureWorsening Heart Failure
Phase 4
Unknown Phase
A Study to Learn More About the Safety of the Drug Vericiguat in Japanese People With Chronic Heart Failure Who Will be Receiving Vericiguat Under Real-world Conditions
RecruitingNCT05666518
Start: 2022-08-31End: 2028-12-31Target: 1400Updated: 2026-07-06
An Observational Study, Called VERI-China, to Learn More About How Well Vericiguat Works and How Safe it is in Real-world Setting in People With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) in China
CompletedNCT05728502
Start: 2023-04-25End: 2025-12-26Updated: 2026-01-30
An Observational Study to Learn More About the Use of Vericiguat in Korean People With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) in Real-world Setting
RecruitingNCT06148935
Start: 2023-11-30End: 2027-10-31Target: 1350Updated: 2026-07-06
An Observational Study to Learn More About Vericiguat Treatment Patterns and Its Safety in People With Chronic Heart Failure With Reduced Ejection Fraction in Routine Medical Care in the United States
CompletedNCT06363110
Start: 2024-04-10End: 2024-06-24Updated: 2024-07-03
An Observational Study Called ROVER to Learn More About How Well Vericiguat Works in People Who Were Newly Treated With Vericiguat in Routine Medical Care in Germany
CompletedNCT06486844
Start: 2024-07-05End: 2025-08-31Updated: 2026-08-31
An Observational Study to Learn More About How Safe Vericiguat is and How Well it Works in Indian People With Chronic Heart Failure With Reduced Ejection Fraction and Worsening Chronic Heart Failure Under Real World Conditions
Active, not recruitingNCT06632483
Start: 2025-09-08End: 2026-06-30Updated: 2026-06-02